NCT07911618
Data Collection For Patients With Sickle Cell Disease
StatusNot Yet Recruiting
PhaseNot specified
SponsorM.D. Anderson Cancer Center
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
safety and adverse events (AEs)
Timeframe: Through study completion; an average of 1 year
Arms and interventions
Other: data collection
Sites
1 site in 1 country
- UT MD Anderson Cancer CenterHouston, Texas, United States